Spine Metastasis
9
1
1
2
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
22.2%
2 terminated out of 9 trials
50.0%
-36.6% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (9)
Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic Disease
Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.
Short Interval Postoperative Stereotactic Body Radiation Therapy (SBRT) After Surgical Intervention for Spine Metastases
A Phase II Trial Evaluating Radiation Boost to Painful Spinal Metastases
A Study of Kyphoplasty and Vertebroplasty in the Treatment of Spine Metastases
A Pilot Study to Explore Serum and Imaging Biomarkers in Patients With Spinal Cord Compression
A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)
Diffusion-Weighted Magnetic Resonance Imaging
Spinal met_radiosurgery/SBRT Study